The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Corpus Christi 361-985-0600 San Antonio 210-656-1000 Nationwide Toll Free 888-314-9945
Contact us 24/7

Painkiller Denied Approval Due to Overdose Risk

View all
Mario Rosales2 years ago

An experimental painkiller used to treat opiate addiction was not approved by a Food and Drug Administration (FDA) advisory panel. Purdue’s Pharma opiate painkiller has been linked to a possible overdose risk.

Description of Health Hazard

FOX News reports that the FDA panel voted against the approval of an experimental painkiller.  The drug was manufactured by Collegium Pharmaceuticals.

The painkiller was designed as an abuse-deterrent fast-acting form of opioid painkiller oxycodone. However, concern has grown because many believe that the pill can be used wrongly. According to several news outlets, the FDA voted against the approval in a 23 to 1 vote.

About the Experimental Painkiller

  • The drugs is called Avridi and it is among the first few drugs to be evaluated by the FDA for the efficacy of such formulations' abuse-deterrent properties.
  • Avridi is designed to be taken every 4-6 hours on an empty stomach and the presence of food could cause inadequate pain control. Inadequate pain control could lead to patients taking more of the drug.
  • An estimated 46 people die every day in the United States from opioid painkiller overdose, according to The Centers for Disease Control and Prevention.


Contact Us for a FREE Case Review

888-314-9945 •